ICON has extensive experience in cardiovascular clinical research trials across the entire drug development spectrum.
Despite the advances in the cardio-metabolic field over the past 20 years, cardiovascular and metabolic diseases remain the leading causes of morbidity and mortality worldwide. The need to discover and develop better, safer and more cost-effective drugs and devices remains.
ICON, a full-service provider, takes a data-driven approach to develop strategies that will cut timelines and costs from First-in-Human (FIH) studies through post-approval. We have over 25 years of experience conducting cardiovascular trials with particular emphasis on key cardiovascular/metabolic indications: heart failure, lipid disorders, diabetes, renal insufficiency and renal transplant, arrhythmia, and rare diseases.
ICON Cardiovascular experience in the last five years
36,415
Patients118
Studies3,929
Sites
ICON's experienced cardio-metabolic drug and medical device development teams support clinical trials across multiple indications, including:
Cardiovascular
- Atrial and Ventricular Arrhythmia
- Cardiomyopathy (e.g., ATTR, hypertrophic, etc. with rare disease team)
- Heart failure
- Hypertension
- Pulmonary Hypertension (with the respiratory team)
- Coronary Artery Disease and Stable Angina
- Acute Coronary syndromes, including myocardial infarction
- Venous Thromboembolism
- Peripheral Arterial Disease
Atherosclerotic & embolic cerebrovascular disease
- Stroke, TIA (with neurosciences team)
Metabolic
- Diabetes
- Dyslipidemia
- Hyperuricemia
ICON services across all phases of drug and device development for your cardio-metabolic trials:
- Medical Device & Diagnostics ResearchICON has deep experience with the development and commercialisation of medical devices, medical device software, in vitro diagnostics, drug delivery systems/devices and combination products across all key cardiovascular indications.
- Adaptive Study DesignMarket-leading simulation software and methods to perfect trial design
- Phase I ResearchA 120-bed unit with pharmacy, labs, and ECG system.
- Feasibility AssessmentAccess to a global team of experts and data scientists using an evidence-based approach to accurately estimate enrolment and study timelines.
- Site & Patient SolutionsTransforming recruitment through patient-centric trials and real-world, real-time data
- Medical ImagingIntegrated solutions based on the science of imaging biomarkers and experience in all cardiovascular imaging modalities.
- Endpoint Adjudication Services Endpoint Adjudication can help lower the risk of variation in important clinical trial outcome events for submission to regulatory agencies.
- Central LaboratoriesGlobal central laboratories with industry-leading accuracy for CVM study endpoints.
Medical Device & Diagnostics Research
ICON has deep experience with the development and commercialisation of medical devices, medical device software, in vitro diagnostics, drug delivery systems/devices and combination products across all key cardiovascular indications.
Adaptive Study Design
Market-leading simulation software and methods to perfect trial design
Phase I Research
A 120-bed unit with pharmacy, labs, and ECG system.
Feasibility Assessment
Access to a global team of experts and data scientists using an evidence-based approach to accurately estimate enrolment and study timelines.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data
Medical Imaging
Integrated solutions based on the science of imaging biomarkers and experience in all cardiovascular imaging modalities.
Endpoint Adjudication Services
Endpoint Adjudication can help lower the risk of variation in important clinical trial outcome events for submission to regulatory agencies.
Central Laboratories
Global central laboratories with industry-leading accuracy for CVM study endpoints.
Dedicated specialist teams
ICON has a global team of in-house cardio-metabolic experts who are highly-experienced in clinical research and drug and device development. The group includes representatives from all critical functional areas and oversees trial operations in order to anticipate and proactively address potential roadblocks. We also leverage established and new relationships with renowned cardio-metabolic experts and investigators worldwide to benefit our clients.
In addition to providing support and guidance to the study team, our cardio-metabolic experts provide insight on:
- Global project feasibility
- Protocol development, review and evaluation
- Clinical trial planning
- Therapeutic training and advice
- Project oversight
- Consulting, medical monitoring and advisory board representation
- Interpretation of the clinical data
- Completion of the clinical study report
Accellacare
Our global investigator database includes over 5,800 cardiovascular investigative sites across more than 55 countries. As such, we have established solid working relationships with leading cardiovascular sites in all regions of the world, enabling us to provide our sponsors with efficient recruitment strategies tailored to each study.
Learn moreCardiovascular, Metabolic and Circulation insights
ICON's Cardiovascular team contributes regularly to industry publications and media coverage of cardiovascular clinical trials. Stay up to date with ICON's latest thought leadership on cardiovascular clinical trials.
Read more